October 24, 2016 5:01 PM ET


Company Overview of Salmedix Inc.

Company Overview

As of June 14, 2005, Salmedix Inc. was acquired by Cephalon, Inc. Salmedix, Inc., a development stage company, operates as an oncology drug development company. It focuses on the treatment of hematologic malignancies or blood cancers. SDX-105, the company’s lead product candidate is primarily used for the treatment of several blood cancers. Salmedix is conducting Phase II clinical trials for SDX-105 in the U.S. and Canada. Its two other clinical-stage product candidates, SDX-101 and SDX-102, are also in Phase II development. SDX-101 has direct anti-tumor activity and also enhances the activity of traditional chemotherapeutic agents by a previously unrecognized mechanism. SDX-102 is a small m...

9380 Judicial Drive

San Diego, CA 92121

United States

Founded in 2000

42 Employees





Key Executives for Salmedix Inc.

Salmedix Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Salmedix Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.